The Use Of Intermittent Enzalutamide Dosing In The Treatment Of Metastatic Castrate-Resistant Prostate Cancer

Michael Rowe,Ayesha Hidayat,Stuart Walter,Adam Pollard,Timothy Norris,Deborah Victor,John McGrane,Alastair Thomson

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 2|浏览12

暂无评分

摘要

81Background: Intermittent hormone manipulation in castrate-sensitive prostate cancer can improve quality of life whilst maintaining comparable disease outcomes with continuous scheduling. Enzaluta...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要